Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

Yuzhong Cui(Tianjin Medical University Cancer Institute and Hospital), Baosheng Li(Shandong First Medical University), Wei Huang(Innovation Team (China)), Lei Feng(Dalian Medical University), Feng Du, Xiaoyang Yin(Qingdao University)
Clinical & Translational Oncology
December 6, 2022
Cited by 0


Related Papers